BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30489053)

  • 1. Acquired Factor Xiii Deficiency: An Uncommon But Easily Missed Cause Of Severe Bleeding.
    Fogarty H; Byrne M; O’Connell NM; Ryan K; White B; O’Donnell JS; Lavin M
    Ir Med J; 2018 May; 111(5):757. PubMed ID: 30489053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
    Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
    Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of acquired FXIII deficiency with severe bleeding symptoms.
    Hayashi T; Kadohira Y; Morishita E; Asakura H; Souri M; Ichinose A
    Haemophilia; 2012 Jul; 18(4):618-20. PubMed ID: 22356719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A child with acquired factor XIII deficiency: case report and literature review.
    Kessel R; Hu C; Shore-Lesserson L; Rand J; Manwani D
    Haemophilia; 2013 Nov; 19(6):814-26. PubMed ID: 23607876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing.
    Kleber C; Sablotzki A; Casu S; Olivieri M; Thoms KM; Horter J; Schmitt FCF; Birschmann I; Fries D; Maegele M; Schöchl H; Wilhelmi M
    Crit Care; 2022 Mar; 26(1):69. PubMed ID: 35331308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series.
    Tone KJ; James TE; Fergusson DA; Tinmouth A; Tay J; Avey MT; Kilty S; Lalu MM
    Transfus Med Rev; 2016 Jul; 30(3):123-31. PubMed ID: 27167905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination.
    Luo YY; Zhang GS
    Haemophilia; 2011 May; 17(3):393-8. PubMed ID: 21323797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevant bleeding diathesis due to acquired factor XIII deficiency.
    Janning M; Holstein K; Spath B; Schnabel C; Bannas P; Bokemeyer C; Langer F
    Hamostaseologie; 2013; 33 Suppl 1():S50-4. PubMed ID: 24169946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired coagulation factor XIII deficiency: a case report.
    Jia Y; Hu H; Wei B
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):454-6. PubMed ID: 26588447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
    Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of factor XIII deficiency.
    Dorgalaleh A; Tabibian S; Hosseini MS; Farshi Y; Roshanzamir F; Naderi M; Kazemi A; Zaker F; Aghideh AN; Shamsizadeh M
    Hematology; 2016 Aug; 21(7):430-9. PubMed ID: 27077776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
    Levy JH; Greenberg C
    Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide.
    Tosetto A; Rodeghiero F; Gatto E; Manotti C; Poli T
    Am J Hematol; 1995 Jan; 48(1):34-9. PubMed ID: 7832189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
    Matsuoka M; Majima T; Onodera T; Ieko M; Souri M; Ichinose A; Kurita T; Kasahara Y; Inoue M; Takahashi D
    Int J Hematol; 2012 Dec; 96(6):781-5. PubMed ID: 23070535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplasm-induced bleeding in inherited, heterozygous FXIII-A deficiency.
    Ivaškevičius V; Goldmann G; Biswas A; Westhofen P; Thomas A; Marquardt N; Horneff S; Klein C; Rühl H; Pötzsch B; Oldenburg J
    Hamostaseologie; 2015; 35 Suppl 1():S32-5. PubMed ID: 26540128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired factor XIII deficiency: A review.
    Yan MTS; Rydz N; Goodyear D; Sholzberg M
    Transfus Apher Sci; 2018 Dec; 57(6):724-730. PubMed ID: 30446212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
    Ajzner E; Schlammadinger A; Kerényi A; Bereczky Z; Katona E; Haramura G; Boda Z; Muszbek L
    Blood; 2009 Jan; 113(3):723-5. PubMed ID: 18955560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII deficiency management: a review of the literature.
    Odame JE; Chan AK; Wu JK; Breakey VR
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):199-205. PubMed ID: 24401950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe inhibitor-negative acquired factor XIII/13 deficiency with aggressive subdural haemorrhage.
    Kawano H; Yamamoto D; Uchihashi Y; Wakahashi K; Kawano Y; Sada A; Minagawa K; Katayama Y; Kohmura E; Souri M; Ichinose A
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):638-41. PubMed ID: 23511901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.